[11] Semaglutide (Wegovy) a GLP-1 receptor agonist approved by the MHRA for chronic weight management
When you increase retatrutide, you are ramping three simultaneously
The TGAs medicine information describes tirzepatide as acting on both GIP and GLP-1 receptors, reducing food intake, regulating appetite, delaying gastric emptying and improving glycaemic control
If you cant keep fluids down or are experiencing significant diarrhea or vomiting, blood in your stool or urine, or a high fever, seek medical attention
These types of irresponsible GLP-1 prescription practices are fueling demand for these medications, sometimes for cosmetic or vanity uses, even when drugs like Ozempic and Wegovy have been in short supply
Citrus and tomato products: these increase esophageal irritation when acid exposure is already elevated